SCHEMBL19600437

SCHEMBL19600437

c1ccc(-c2cc(-c3ccccc3)cc(-c3ccc4c5c(cccc35)Oc3cc(-c5ccc6oc7ccccc7c6c5)ccc3-4)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 5/20 0.41
PLA2G4A P47712 5/20 0.41
PLA2G10 O15496 1/20 0.41
KDM4E B2RXH2 2/20 0.35
NPC1 O15118 2/20 0.35
HPGD P15428 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
PRKDC P78527 3/20 0.34
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
MAPK1 P28482 1/20 0.33
ATM Q13315 1/20 0.33
AHR P35869 1/20 0.33
ALOX5 P09917 1/20 0.32
CASP3 P42574 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19600414 0.94 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10KDM4ENPC1
SCHEMBL20305991 0.85 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10KDM4ENPC1
SCHEMBL19600397 0.85 ATM (0.42) PLA2G2APLA2G4APLA2G10KDM4ENPC1
SCHEMBL17265407 0.83 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10KDM4ENPC1
SCHEMBL26164483 0.83 CHEK2 (0.34) PLA2G2APLA2G4APLA2G10KDM4ENPC1
SCHEMBL19600408 0.82 KDM4E (0.35) PLA2G2APLA2G4APLA2G10KDM4EHPGD
SCHEMBL24734810 0.82 ALDH1A1 (0.42) PLA2G2APLA2G4APLA2G10KDM4ENPC1
SCHEMBL22876610 0.82 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10KDM4ENPC1
SCHEMBL17886391 0.82 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10KDM4ENPC1
SCHEMBL26750769 0.82 PLA2G2A (0.52) PLA2G2APLA2G4APLA2G10KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10573825-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-25 US disclosed
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-16 US disclosed
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10573825-B2 Compound and organic light-emitting device including the same CRY1, CRY2, AOX1 PLA2G2A 4172/4885PLA2G4A 4050/4885PLA2G10 4191/4885
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, AOX1 PLA2G2A 4172/4885PLA2G4A 4050/4885PLA2G10 4191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.